Reply to the letter to the editor: DPD testing in radical chemoradiation for anal squamous cell carcinoma? by R. Muirhead, H. Jones, D. Gilbert, A. Gilbert & C. Jacobs

Ann Oncol. 2020 Nov;31(11):1587-1588. doi: 10.1016/j.annonc.2020.08.2097. Epub 2020 Aug 19.

Authors

R Glynne-Jones¹, H M Meadows², A Lopes², R Muirhead³, D Sebag-Montefiore⁴, R Adams⁵

Affiliations

¹ Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, UK. Electronic address: rob.glynnejones@nhs.net.
² Cancer Research UK & University College London Cancer Trials Centre, UCL, London, UK.
³ Oxford Cancer & Haematology Centre, Oxford University Hospitals, Oxford, UK.
⁴ University of Leeds, Leeds Cancer Centre, Leeds, UK.
⁵ School of Medicine, Cardiff University, Cardiff, UK.

PMID: 32822831
DOI: 10.1016/j.annonc.2020.08.2097

No abstract available

Publication types

Letter
Comment

MeSH terms

Anal Canal
Anus Neoplasms* / drug therapy
Carcinoma, Squamous Cell* / drug therapy
Chemoradiotherapy
Humans

Grants and funding